Live Breaking News & Updates on ஜெநெடிக் அறிவியல்|Page 15

Stay updated with breaking news from ஜெநெடிக் அறிவியல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Novel CRISPR-based gene editor developed to correct mutations that cause genetic disorders


Novel CRISPR-based gene editor developed to correct mutations that cause genetic disorders
A team of researchers from the Agency for Science, Technology and Research s (A STAR) Genome Institute of Singapore (GIS) have developed a CRISPR-based gene editor, C-to-G Base Editor (CGBE), to correct mutations that cause genetic disorders. Their research was published in
Nature Communications on 2 March 2021.
One in seventeen people in the world suffers from some type of genetic disorder. Chances are, you or someone you know - a relative, friend, or colleague - is one of approximately 450 million people affected worldwide. Mutations responsible for these disorders can be caused by multiple mutagens - from sunlight to spontaneous errors in your cells. The most common mutation by far is the single-based substitution, in which a single-base in the DNA (such as G) is replaced by another base (such as C). Countless cystic fibrosis patients worldwide have C instead of G, leading to ....

Kwei Leong , Emily Henderson , Agency For Science , Genome Institute Of Singapore , Nature Communications , Senior Research Scientist , Genome Institute , C Tog Base Editor , Chew Wei Leong , Young Scientist Award , Patrick Tan , Executive Director , Cystic Fibrosis , Genetic Disorder , வெய் லியோங் , எமிலி ஹென்டர்சன் , மரபணு நிறுவனம் ஆஃப் சிங்கப்பூர் , இயற்கை தகவல்தொடர்புகள் , மூத்தவர் ஆராய்ச்சி விஞ்ஞானி , மரபணு நிறுவனம் , மெல் வெய் லியோங் , இளம் விஞ்ஞானி விருது , பேட்ரிக் பழுப்பு , நிர்வாகி இயக்குனர் , சிஸ்டிக் ஃபைப்ரோஸிஸ் , ஜெநெடிக் கோளாறு ,

Henry Ford Cancer Institute launches new initiative to improve minority participation in clinical trials


Henry Ford Cancer Institute launches new initiative to improve minority participation in clinical trials
Henry Ford Cancer Institute is launching the Participatory Action for Access to Clinical Trials (PAACT) project to dramatically improve the representation of the African American community and other minorities in cancer clinical trials.
Supported by a $750,000 grant from Genentech, PAACT is a community-based research initiative in collaboration with the Detroit Community-Academic Urban Research Center (Detroit URC) that will address various barriers to trust and participation in clinical trials. Researchers and community partners will focus on clinical trials involving breast, colorectal, lung, and prostate cancers, which are more likely to result in death for African Americans when compared to other racial and ethnic groups. The project is being implemented in partnership with community-based organizations and community leaders who are key stakeholders. ....

United States , Grace Community Church , Mary Waters , Eleanorm Walker , Sophia Chue , Donnam Harris , Emily Henderson , Parkside Zachary Rowe , Evelyn Jiagge , Henry Ford , Benjamin Movsas , Eastside Community Network Jillian Dewitt , Integrative Services , Academic Urban Research Center Detroit , Institute For Population Health Gwendolyn Daniels , Community Advocacy , Henry Ford Cancer Institute , Ghana Association , Neighborhood Service Organization Linda Little , Um School Of Nursing , Steering Committee , Detroit Community , Caribbean Community Service Center , Henry Ford Breast Cancer Research , Um School Of Public Health , Ford Cancer Institute ,

Tiny antibodies naturally generated by llamas can be effective against COVID-19


Tiny antibodies naturally generated by llamas can be effective against COVID-19
As the fight against COVID-19 continues, scientists have turned to an unlikely source for a potentially effective treatment: tiny antibodies naturally generated by llamas.
While the world has welcomed the news of multiple vaccines against COVID-19, the search for effective treatments for those who contract the virus is ongoing. Now scientists are looking to what might seem to be an unlikely source: the South American llama.
Researchers are using the ultrabright X-rays of the Advanced Photon Source (APS), a U.S. Department of Energy (DOE) Office of Science User Facility at DOE s Argonne National Laboratory, to help turn naturally generated llama antibodies into potentially effective therapies against SARS-CoV-2, the virus that causes COVID-19. Antibodies are the immune system s natural defense against infection, and when extracted from blood, they can be used to design treatments and vaccine ....

United States , Nordrhein Westfalen , University Of Texas , Yufei Xiang , Jason Mclellan , Emily Henderson , Xavier Saelen , Yi Shi , Ian Wilson , Cheng Zhang , Andrzej Joachimiak , Daniel Wrapp , Scripps Research Institute , National Institutes Of Health , National Institute Of Arthritis , National Cancer Institute Structural Biology Facility , Us Department Of Energy , Office Of Science User Facility , University Of Texas At Austin , University Of Bonn , University Of Pittsburgh , Argonne National Laboratory , Structural Biology Center , National Institute , South American , Advanced Photon Source ,

New compound can reduce overactivation without impairing the body's immunity response


New compound can reduce overactivation without impairing the body s immunity response
When the body detects a pathogen, such as bacteria or viruses, it mounts an immune system response to fight this invader. In some people, the immune system overreacts, resulting in an overactive immune response that causes the body to injure itself, which may prove fatal in some cases.
Now, scientists from Nanyang Technological University, Singapore (NTU Singapore) have created a compound that could help to reduce this overactivation without impairing the body s entire immune response.
An overactive immune system leads to many autoimmune disorders - when the immune system mistakenly attacks healthy tissues - such as rheumatoid arthritis and type 1 diabetes. More recently, it has also been linked to severe COVID-19 infections, in which immune-system signalling proteins ramp up to dangerous levels, leading to damage to the body s own cells. ....

United States , Phan Anh Tuan , Phan Anh , Emily Henderson , American Association Of Immunologists , Nanyang Technological University , Mathematical Sciences , Institute Of Structural Biology , University Of Edinburgh , Professor Phan Anh Tuan , Interim Director , Structural Biology , Nanyang Technological , Lim Kah Wai , United Kingdom Led , American Association , Immune Response , Immune System , Rheumatoid Arthritis , Type 1 Diabetes , ஒன்றுபட்டது மாநிலங்களில் , ஃப்யாந் அந்த் ட்யூவாந் , ஃப்யாந் அந்த் , எமிலி ஹென்டர்சன் , அமெரிக்கன் சங்கம் ஆஃப் நோயெதிர்ப்பு நிபுணர்கள் , கணித அறிவியல் ,